Caption Management »

Aeglea Biotherapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.3M 135k 16.76
2025-06-30 $1.6M 110k 14.97

More positions owned by Caption Management

Carvana Cl A Call Option (CVNA)
Coreweave Com Cl A Call Option (CRWV)
Intuit Call Option (INTU)
Tesla Motors Put Option (TSLA)
United Therapeutics Corporation Call Option (UTHR)
Amazon Put Option (AMZN)
Reddit Cl A Call Option (RDDT)
Applovin Corp Com Cl A Call Option (APP)
NVIDIA Corporation Put Option (NVDA)
Echostar Corp Cl A Call Option (SATS)
Chevron Corporation Call Option (CVX)
Sable Offshore Corp Com Shs Call Option (SOC)
Iren Ordinary Shares Call Option (IREN)
Core Scientific Call Option (CORZ)
Coinbase Global Com Cl A Call Option (COIN)

View all positions for Caption Management

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics